Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Previously submitted to: JMIR mHealth and uHealth (no longer under consideration since Apr 01, 2019)

Date Submitted: Sep 28, 2018
Open Peer Review Period: Oct 6, 2018 - Dec 1, 2018
(closed for review but you can still tweet)

NOTE: This is an unreviewed Preprint

Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).

Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.

Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).

Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.

Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.

Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Safe and Easy Environment for frailty syndrome: a randomized controlled trial at patient home.

  • Valeria Manera; 
  • Philippe Robert; 
  • Alexandre Derreumaux; 
  • Leon Chicheportiche; 
  • Maria Katsogiannou; 
  • Laurent Moy; 
  • Stephane Guetin; 
  • Roxane Fabre; 
  • Julie de Stoutz; 
  • Pau-Choo Chung; 
  • François Bremond; 
  • Renaud David; 
  • Auriane Gros

Background:

All over the world the increasing prevalence of age-related disorders such as Alzheimer’s disease (AD) and frailty and its impact on functional decline is challenging the sustainability of health care systems. In the field of AD and related disorders, Information and Communication technologies (ICT) showed promising results in improving clinical assessment and implementing interventions to delay functional decline and decrease the burden of behavioral symptoms.

Objective:

The SafEE (Safe Easy Environment) project, is a collaborative French-Taiwanese project aiming to develop: 1/ an ICT-based behavior analysis platform able to automatically detect, recognize and assess daytime and nighttime behavioral patterns, and 2/ adapted tailored non pharmacological interventions. Partners of the projects include clinicians, research engineers and industrials.

Methods:

This study was designed as a randomized controlled trial. We recruited 3 patients with cognitive frailty syndrome [≥ 60 years, MMSE ≥ 26, CDR ≤ 0.5] randomized either to the intervention group (ICT-based therapeutic solutions, N=1) or to the control group (care as usual, N=2). The 6-month intervention included detection of daytime and nighttime behaviors based on 2D and 3D video cameras (for both groups), and tailored therapeutic solutions based on serious-games, aromatherapy and music therapy for the intervention group. The primary outcome is the acceptability of the solutions measured by the frequency of use and self-reports. The secondary outcome is the solution efficacy, measured by the results on neuropsychological tests.

Results:

This project made it possible to develop a communicating platform between the automatic recognition of activity and the non-pharmacological solutions developed. This platform is thus able to 1) provide healthcare professionals with continuous feedback on immediate and long-term risk events; 2) Automatically combine an online assessment with non-pharmacological interventions that can act on the detected disorders; 3) obtain relevant information in the context of an early diagnosis at home of frail people at risk of developing Alzheimer's disease.

Conclusions:

Building a global system aiming to detect and prevent loss of autonomy in frail people is a rather complicated task, involving numerous ICT solutions which are not always easy to use in everyday life. The innovation of the project lies in a new methodological approach to deal with care of elderly people, based on an innovative use of ICT based on the association of assessment and intervention for specific cognitive and behavioral patterns. The results of this trial may have important implications for future interventions, and provide relevant information for the general transferability of this platform as part of the AD prevention.

ClinicalTrial:

ClinicalTrials.gov, NCT02288221. First received: August 19, 2014. Last updated: November 7, 2014. Last verified: June 2014.


 Citation

Please cite as:

Manera V, Robert P, Derreumaux A, Chicheportiche L, Katsogiannou M, Moy L, Guetin S, Fabre R, de Stoutz J, Chung PC, Bremond F, David R, Gros A

Safe and Easy Environment for frailty syndrome: a randomized controlled trial at patient home.

JMIR Preprints. 28/09/2018:12357

DOI: 10.2196/preprints.12357

URL: https://preprints.jmir.org/preprint/12357

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.